6550--Molecular Oncology-MSI Testing

The Department of Veterans Affairs VISN 22 Network Contracting Office is issuing a Sources‑Sought/RFI to identify qualified vendors that can provide MSI Testing Reagent Cartridges on a rental basis for in‑house single‑gene molecular testing at the VA Greater Los Angeles Healthcare System. The required assay must be fully automated, ready‑to‑use with no reagent preparation or sample extraction, deliver results in approximately 150 minutes, accept a minimum of one FFPE tissue slice, eliminate the need for external quality control, and qualitatively detect mutations in seven novel MSI loci (ACVR2A, BTBD7, DIDO1, MRE11, RYR3, SEC31A, and SULF2). The VA seeks a brand‑name product or an “equal‑to” solution that meets all of these salient characteristics, with an anticipated annual need of 50 MSI assay cartridges, 1 console, and 3 instruments (Biocartis Idylla platform). Respondents must provide company information (address, point of contact, UEI), size status under NAICS 325413 (size standard 1,250 employees), and indicate any Service‑Disabled Veteran‑Owned, Veteran‑Owned, HUBZone, Women‑Owned, or large‑business designations. Vendors should disclose whether they hold a GSA/FSS, NAC, NASA SEWP, or other federal contract for the items, the contract number, and if the products are available on that schedule. Required disclosures also include manufacturer or distributor status, country of origin, any alteration/assembly of the items, and general pricing for market research. Responses are to be submitted via email to Samuel.Han@va.gov; this RFI is for information and planning purposes only and does not constitute a solicitation.

Notice ID

9eae9c81441549ffa6cbfe05b0c7a734

Solicitation Number

36C26226Q0668

NAICS Code

325413

Classification Code

6550